$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
As a live-cell DFS technique, BFP engineers a human red blood cell (RBC; Figure 1) into an ultrasensitive and tunable force transducer with a compatible spring constant range at 0.1-3 pN/nm1,2,3. To probe ligand-receptor interaction, BFP enables DFS measurements at ~1 pN (10-12 N), ~3 nm (10-9 m), and ~0.5 ms (10-3 s) in force, spatial, and temporal resolution4,5. Its experimental configuration consists of two opposing micropipettes, namely the Probe and the target. The Probe micropipette aspirates a RBC and a bead is glued at its apex via a biotin-streptavidin interaction. The bead is coated with the ligand of interest (Figure 1A). The Target micropipette aspirates either a cell or a bead bearing the receptor of interest, corresponding to the Bead-Cell (Figure 1B) and Bead-Bead (Figure 1C) modes, respectively5.
BFP construction, assembly and the DFS experimental protocols were described in detail previously1,6. Briefly, a BFP touch cycle consists of 5 stages: Approach, Impinge, Contact, Retract and Dissociate (Figure 1D). The horizontal RBC apex position is denoted as ΔxRBC. At the beginning, the unstressed (zero-force) RBC deformation ΔxRBC is 0 (Table 1). The Target is then driven by a piezotranslator to impinge on and retract from the Probe bead (Figure 1D). The RBC probe is first compressed by the Target with negative RBC deformation ΔxRBC < 0. In a Bond event, the Retract stage transitions from a compressive to a tensile phase with positive RBC deformation ΔxRBC > 0 (Figure 2C and D). According to Hooke's law, the BFP bearing force is able to be measured as F = kRBC × ΔxRBC, where kRBC (Table 1) is the RBC spring constant of the BFP. Upon bond rupture and the completion of one touch cycle, the probe bead returns to zero-force position with ΔxRBC = 0 (Figure 1D).
To determine the kRBC, we measure and record the radii of the probe micropipette inner orifice (Rp), the RBC (R0) and the circular contact area (Rc) between the RBC and the probe bead (Figure 1A). Then kRBC is calculated according to the Evan's model (Eq. 1)7,8 using a LabVIEW program that acts as a virtual instrument (VI) to operate the BFP (Figure S1A)8,9.
(Eq. 1)
With a BFP established and DFS raw data obtained, hereby we present how to analyze the spring constant of ligand-receptor pair or cells. The DFS raw data on the interaction of the glycosylated protein Thy-1 and K562 cell bearing integrin α5β1 (Thy-1-α5β1; Figures 3A and 3B)10 and that of the fibrinogen and bead coated integrin αIIbβ3 (FGN-αIIbβ3; Figure 3C)11,12 have been used to demonstrate the Bead-Cell and Bead-Bead analysis modes, respectively.
BFP Experimental Preparation
For details of BFP experimental preparation and instrumentation, please refer to the previously published protocols3. In brief, human RBC has been biotinylated using the Biotin-PEG3500-NHS in the carbon/bicarbonate buffer. Proteins of interest have been covalently coupled to the borosilicate glass beads using MAL-PEG3500-NHS in the phosphate buffer. To attach to the biotinylated RBC, the probe bead is also coated with streptavidin (SA) using the MAL-SA. Please see the Table of Materials and Table 2.
To assemble the BFP (Figure 1, left), the third micropipette termed 'Helper' will be used to deliver the probe bead and glue it to the RBC's apex1,3. The covalent interaction between the SA coated probe bead and biotinylated RBC is much stronger than the ligand-receptor bond of interest. Thus, the Dissociate stage can be interpreted as the ligand-receptor bond rupture rather than the detachment of Probe bead from the RBC.